-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Maintains Overweight on WAVE Life Sciences, Raises Price Target to $41

Benzinga·02/05/2026 14:23:41
Listen to the news
Cantor Fitzgerald analyst Steve Seedhouse maintains WAVE Life Sciences (NASDAQ:WVE) with a Overweight and raises the price target from $34 to $41.